These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10551971)

  • 1. Orphenadrine poisoning in a child: clinical and analytical data.
    Van Herreweghe I; Mertens K; Maes V; Ramet J
    Intensive Care Med; 1999 Oct; 25(10):1134-6. PubMed ID: 10551971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of orphenadrine-induced ventricular tachycardia with physostigmine.
    Danze LK; Langdorf MI
    J Emerg Med; 1991; 9(6):453-7. PubMed ID: 1787292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study.
    Dhaliwal N; Roberts DM
    Clin Toxicol (Phila); 2024 Mar; 62(3):168-173. PubMed ID: 38525870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of physostigmine on respiratory and circulatory changes caused by overdoses of orphenadrine or imipramine in the rat.
    Zandberg P; Sangster B
    Acta Pharmacol Toxicol (Copenh); 1982 Mar; 50(3):185-95. PubMed ID: 7090842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full recovery from a potentially lethal dose of orphenadrine ingestion using conservative treatment: a case report.
    Mao YC; Hung DZ; Yang CC; Wang JD
    Hum Exp Toxicol; 2010 Nov; 29(11):961-3. PubMed ID: 20200196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful management of olanzapine-induced anticholinergic agitation and delirium with a continuous intravenous infusion of physostigmine in a pediatric patient.
    Hail SL; Obafemi A; Kleinschmidt KC
    Clin Toxicol (Phila); 2013 Mar; 51(3):162-6. PubMed ID: 23473460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central anticholinergic syndrome from orphenadrine in a 3 year old.
    Garza MB; Osterhoudt KC; Rutstein R
    Pediatr Emerg Care; 2000 Apr; 16(2):97-8. PubMed ID: 10784211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute poisoning by orphenadrine].
    Elmalem J; Garnier R; Nguyen Huu Chieu R; Bismuth C; Efthymiou ML
    Ann Med Interne (Paris); 1985; 136(8):640-5. PubMed ID: 3833010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of depressant actions of orphenadrine and diazepam on hypertonic skeletal muscle activity.
    Williamson HE
    Arch Int Pharmacodyn Ther; 1989; 301():112-21. PubMed ID: 2624511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Etiology of initially unexplained confusion of excitability in deadly nightshade poisoning with suicidal intent. Symptoms, differential diagnosis, toxicology and physostigmine therapy of anticholinergic syndrome].
    Heindl S; Binder C; Desel H; Matthies U; Lojewski I; Bandelow B; Kahl GF; Chemnitius JM
    Dtsch Med Wochenschr; 2000 Nov; 125(45):1361-5. PubMed ID: 11109424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physostigmine as treatment for severe CNS anticholinergic toxicity.
    Teoh R; Page AV; Hardern R
    Emerg Med J; 2001 Sep; 18(5):412. PubMed ID: 11559630
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fatalities caused by anticholinergic antiparkinsonian drugs. Analysis of findings in a 11-year national material].
    Gjerden P; Engelstad KS; Pettersen G; Slørdal L
    Tidsskr Nor Laegeforen; 1998 Jan; 118(1):42-4. PubMed ID: 9481909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical pharmacology of anticholinergic antiparkinson agents. A review with emphasis on acute toxicity].
    Gjerden P; Slørdal L
    Tidsskr Nor Laegeforen; 1998 Jan; 118(1):53-5. PubMed ID: 9481912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a physostigmine continuous infusion for the treatment of severe and recurrent antimuscarinic toxicity in a mixed drug overdose.
    Phillips MA; Acquisto NM; Gorodetsky RM; Wiegand TJ
    J Med Toxicol; 2014 Jun; 10(2):205-9. PubMed ID: 24798647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute intoxication with orphenadrine and clozapine.
    Fucci N; Romano B; Zirilli A
    Forensic Sci Int; 2001 Nov; 123(1):13-6. PubMed ID: 11731191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orphenadrine poisoning in childhood.
    Gill DG; Sowerby HA
    Practitioner; 1975 Apr; 214(1282):542-544. PubMed ID: 1144265
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of orphenadrine plasma levels using HPLC with diode array detection and a novel solid-phase extraction procedure in psychiatric patients.
    Saracino MA; Petio C; Vitali M; Franchini L; Raggi MA
    J Pharm Biomed Anal; 2009 Oct; 50(3):501-6. PubMed ID: 19524386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fever, large eyes and confusion; the anticholinergic syndrome].
    Jellema K; Groeneveld GJ; van Gijn J
    Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2173-6. PubMed ID: 12467156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central anticholinergic syndrome: a case report.
    Moos DD
    J Perianesth Nurs; 2007 Oct; 22(5):309-21. PubMed ID: 17900503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimum effective drug concentrations of a transdermal patch system containing procyclidine and physostigmine for prophylaxis against soman poisoning in rhesus monkeys.
    Cho Y; Kim WS; Hur GH; Ha YC
    Environ Toxicol Pharmacol; 2012 Jan; 33(1):1-8. PubMed ID: 22051905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.